by Jackie (née Heneghan) Peck | Mar 20, 2019 | Blog
The role of the RPi is described in regulations 45AA & 45AB of the Human Medicines Regulations 2012 (as amended). The draft legislation is live but not yet approved by the Houses of Parliament…
by John Finey | Mar 18, 2019 | Blog
With everything going on at the moment it is easy to forget that there are things other than Brexit happening. An important one for the pharma supply chain is the scheduling of Pregabalin and Gabapentin as Class C, schedule 3 controlled drugs from 1st April 2019….
by Jackie (née Heneghan) Peck | Mar 18, 2019 | Blog
If a pharmacy allows the pharmacist to supply different strengths, quality or pharmaceutical form or indeed a different medicine to the prescription only medicine prescribed, using the newly agreed “Serious Shortage Protocol” who is liable if the patient...
by Jackie (née Heneghan) Peck | Mar 18, 2019 | Blog
The Government is advising people that they must obtain their own travel insurance after Brexit. This is because the European Health Insurance Card the EHIC will disappear over night. This will also affect all the UK citizens who currently live abroad and take up...
by Jackie (née Heneghan) Peck | Mar 18, 2019 | Blog
From the 1st of April 2019 pregabalin and gabapentin will be re-classified as class C controlled substances in the UK. The change has been prompted due to a sharp increase in deaths which toxicology has proved an association with the medicines. In addition the...
by Suzanne Hayes | Mar 14, 2019 | Blog
“10 day rule” What is the ten day rule? All stakeholders in the medicines supply chain such as, wholesalers, pharmacies, hospitals will have to verify and decommission medicinal products when they are supplied to the patient or a healthcare provider who is...
